ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Atherosclerosis"

  • Abstract Number: 2221 • ACR Convergence 2024

    Association Between Serum Uric Acid/Serum Creatinine Index and Carotid Plaque in Patients with Rheumatoid Arthritis

    Andrea Guajardo Aldaco1, Dionicio Galarza-Delgado2, Iris Jazmín Colunga Pedraza1, jose Ramon Azpiri-Lopez3, Jesus Cardenas-de la Garza4, Rosa Icela Arvizu-Rivera1, Maria F. Elizondo-Benitez5, Valeria Gonzalez-Gonzalez6 and Diego Salcedo-Almanza7, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 3Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 7Division of Radiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease. The serum uric acid/serum creatinine ratio (SUA/SCr), which represents uric acid levels in the blood…
  • Abstract Number: 2235 • ACR Convergence 2024

    The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis

    J. Alex B. Gibbons1, Joan Bathon2 and Jon Giles3, 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Columbia University, NEW YORK, NY, 3Cedars Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Patients with RA are at increased risk of atherosclerotic cardiovascular disease (ASCVD), yet traditional 10-year CVD risk calculators—such as the 2013 Pooled Cohort Equations…
  • Abstract Number: 2239 • ACR Convergence 2024

    Age, Seropositivity and Inflammation Determine Risk versus Benefit of Endogenous Estrogens on Coronary Atherosclerosis in Rheumatoid Arthritis

    George Karpouzas1, Bianca Papotti2, Sarah Ormseth3, Marcella Palumbo2, Elizabeth Hernandez3, Matthew Budoff4 and Nicoletta Ronda2, 1Harbor-UCLA Medical Center, Torrance, CA, 2University of Parma, Parma, Italy, 3The Lundquist Institute, Torrance, CA, 4Harbor-UCLA Medical Center and the Lundquist Institute for Biomedical Innovation, Torrance, CA

    Background/Purpose: Endogenous estrogens (E) appear cardioprotective in women in the general population. Yet, proinflammatory effects were described in chronic autoimmune diseases depending on stage, cell-type…
  • Abstract Number: 2240 • ACR Convergence 2024

    Methotrexate Use Influenced the Effect of Inflammation on Cardiovascular Risk Differently in Anticitrullinated Protein Antibody Negative and Positive Patients with Rheumatoid Arthritis

    George Karpouzas1, Piet Van RIel2, Elena Myasoedova3, Miguel Angel Gonzalez-Gay4, alfonso Corrales-Martínez5, Solbritt Rantapaa-Dahlqvist6, Petros Sfikakis7, Patrick Dessein8, Linda Tsang9, Carol Hitchon10, Hani El Gabalawy11, Virginia Pascual Ramos12, Irazu Contreras Yanez13, Iris Jazmín Colunga Pedraza14, Dionicio Galarza-Delgado15, jose Ramon Azpiri-Lopez16, Anne Grete Semb17, Patrick Durez18, Durga P Misra19, Brian Bridal Logstrup20, Ellen Margrethe Hauge21, George Kitas22 and Sarah Ormseth23, and ATACC-RA, 1Harbor-UCLA Medical Center, Torrance, CA, 2Radboud University Medical Center, Nijmegen, Netherlands, 3Mayo Clinic, Rochester, MN, 4University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 5Hospital Universitario Marques de Valdecilla, Santander, Spain, 6Umeå University, Umeå, Sweden, 7Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens. Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 8University of Witwatersrand, Johannesburg, South Africa, 9University of Witwatersrand, Johanessburg, South Africa, 10University of Mannitoba, Winnipeg, Canada, 11University of Mannitoba, Winnipeg, MB, Canada, 12Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Federal District, Mexico, 13Instituto Nacional de las Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 14Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 15UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 16Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 17Diakonhjemmet Hospital, Oslo, Norway, 18UCLouvain, Louvain, Belgium, 19Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 20University of Aarhus, Aarhus, Denmark, 21Aarhus Universitetshospital, Aarhus, Denmark, 22The Dudley Group NHS Foundation Trust, Birmingham, United Kingdom, 23The Lundquist Institute, Torrance, CA

    Background/Purpose: Disease activity was linked to cardiovascular (CV) risk in rheumatoid arthritis (RA). Anticitrullinated protein antibody (ACPA) positivity associated with greater synovial inflammation, tumor necrosis…
  • Abstract Number: 2414 • ACR Convergence 2024

    A Retrospective Comparative Analysis of Cardiovascular Risk Factors, Atherosclerotic Cardiovascular Disease and Statin Use as Secondary Prevention in a Cohort of Patients with Systemic Lupus Erythematosus versus Without Rheumatological Disease from a Single-Center Patient Registry

    Alma Aveytia Camacho1, Rakesh Gullapelli2, Vineetha Philip3, Soudabeh Daliri1, Ruba Memon4, Helene DiGregorio2, Lily Romero Karam2, Kanika Monga3, Eleonora Avenatti2, Khurram Nasir2 and Myriam Guevara1, 1Houston Methodist, Houston, TX, 2Houston Methodist Hospital, Houston, TX, 3Houston Methodist Hospital, Sugar Land, TX, 4Houston Methodist, Missouri City, TX

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have increased prevalence of cardiovascular risk factors (RFs), which predispose to higher risk of premature atherosclerotic cardiovascular disease…
  • Abstract Number: 0156 • ACR Convergence 2024

    Psoriasis and Psoriatic Arthritis Are Independent Risk Factors for Non-Fatal Cardiovascular Admissions in Transition-Age Young Adults

    Anurag Goel1, Joshua Tanzer2 and Vinit Gilvaz3, 1The Warren Alpert Medical School of Brown University, Providence, RI, 2Lifespan Biostatistics, Epidemiology, Research Design, and Informatics Core, Providence, RI, 3The Warren Alpert Medical School of Brown University, East Providence, RI

    Background/Purpose: Psoriasis (PsO) and psoriatic arthritis (PsA) are closely linked inflammatory conditions that can affect both children and adults. In children, these diseases are associated…
  • Abstract Number: 0229 • ACR Convergence 2024

    An Early Inflammatory Cardiac Phenotype and Association with Future Coronary Plaque Burden in Rheumatoid Arthritis

    Brittany Weber1, Feng Liu2, Mary Jeffway2, Dana Weisenfeld2, Gregory McDermott3, Elena Massarotti2, Jonathan Coblyn2, Michael Weinblatt4, Marcelo Di Carli2, Damini Dey5 and Katherine Liao2, 1Brigham and Women's Hospital, DEDHAM, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Brookline, MA, 4Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 5Cedars-Sinai Medical Center, Los Angeles

    Background/Purpose: Patients with RA are at increased risk of cardiovascular disease (CVD) compared to the general population.  In a prior study of RA patients with…
  • Abstract Number: 0611 • ACR Convergence 2024

    Subclinical Atherosclerosis Is Associated with Future Cardiovascular Events in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Longitudinal Prospective Study

    Arthur Mageau1, Marie-Paule Chauveheid2, Chrystelle Francois2, Thomas Papo1 and Karim Sacré1, 1Université Paris Cité, Paris, France, 2Assistance Publique Hôpitaux de Paris, Paris, France

    Background/Purpose: Cardiovascular events (CVE) are the leading cause of mortality for patients living with systemic lupus erythematosus (SLE). Besides the traditional cardiovascular risk factors, the…
  • Abstract Number: 0838 • ACR Convergence 2024

    The Mechanistic Impact of IgA anti-beta-2 Glycoprotein I on Accelerated Atherosclerosis in Primary APS

    Kavya Sugur1, Emily Chong1, Srilakshmi Yalavarthi2, Katarina Kmetova3, Lyndsay Kluge1, Wenying Liang2, Cyrus Sarosh4, NaveenKumar Somanathapura K2, Jacqueline Madison2, Ajay Tambralli2, Jason Knight2 and Yu Zuo2, 1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI, 3Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA, Ann Arbor, MI, 4University of Michigan, Temperance, MI

    Background/Purpose: Antiphospholipid syndrome (APS) is an acquired thrombo-inflammatory disease characterized by persistent antiphospholipid antibodies (aPL). APS patients experience significant morbidity and mortality, much of which…
  • Abstract Number: 1157 • ACR Convergence 2024

    Reduced Statin Use in Patients with Autoimmune Myopathies and Systemic Lupus Erythematosus Compared to Rheumatoid Arthritis and Non-Inflammatory Diseases

    Shane Cameron, Liam O'Neil, Annaliese Tisseverasinghe and Christine Peschken, University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Rheumatic diseases such as autoimmune myopathy (AIM), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA) confer an increased risk for atherosclerotic disease. The 3-hydroxy-3-methylglutaryl-coenzyme…
  • Abstract Number: 1345 • ACR Convergence 2024

    Long-term Changes in Coronary Calcium Score Levels Among Patients with Rheumatoid Arthritis: A Cohort Study

    Cristina Corrales Selaya1, Nuria Vegas Revenga2, Carmen Secada Gómez3, Jose Antonio parra-Blanco4, Virginia Portilla-González4, Ricardo Blanco-Alonso5, Miguel Angel Gonzalez-Gay6, ivan Ferraz-Amaro7 and alfonso Corrales-Martínez8, 1Rheumatology, Marques de Valdecilla University Hospital. IDIVAL, Santander, Cantabria, Spain, 2Hospital Galdakao- Usansolo, Galdakao, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 4Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 5Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain, 6University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 7Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 8Hospital Universitario Marques de Valdecilla, Santander, Spain

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of subclinical cardiovascular (CV) disease and, consequently, a higher incidence of CV events, compared to the…
  • Abstract Number: 1347 • ACR Convergence 2024

    Interest of DAS28-γGT in Assessing Cardiovascular Risk Activity in Rheumatoid Arthritis in Routine Practice

    Manon Lesturgie-Talarek1, Fabien Picard2, sabrina hamroun3, Malika Saadi2, Camille Macher4, Aude Deloumeau3, Karim Wahbi2, jacques Blacher4, Yannick Allanore5 and Jérôme Avouac6, 1Université de Paris, Institut Cochin, INSERM U1016 CNRS UMR8104, Paris, France, 2Cardiology Department - Cochin Hospital, Paris, France, 3Rheumatology Department - Cochin Hospital, Paris, France, 4Cardiology Department, Hôtel Dieu Hospital, Paris, France, 5Université Paris Cité, Paris, France, 6Rheumatology A Department, Hôpital Cochin, AP-HP Centre - Université Paris Cité, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular (CV) mortality, linked to systemic inflammation and the presence of associated CV risk factors.…
  • Abstract Number: 1361 • ACR Convergence 2024

    The Effect of Disease Activity on Cardiovascular Risk Varies According to Rheumatoid Factor and Anticitrullinated Protein Antibody Status in Patients with Rheumatoid Arthritis

    George Karpouzas1, Virginia Pascual Ramos2, Elena Myasoedova3, Miguel Angel Gonzalez-Gay4, alfonso Corrales-Martínez5, Solbritt Rantapaa-Dahlqvist6, Petros Sfikakis7, Patrick Dessein8, Linda Tsang9, Carol Hitchon10, Hani El Gabalawy11, Piet Van RIel12, Irazu Contreras Yanez13, Iris Jazmín Colunga Pedraza14, Dionicio Galarza-Delgado15, jose Ramon Azpiri-Lopez16, Anne Grete Semb17, Durga P Misra18, Patrick Durez19, Brian Bridal Logstrup20, Ellen Margrethe Hauge21, George Kitas22 and Sarah Ormseth23, and ATACC-RA, 1Harbor-UCLA Medical Center, Torrance, CA, 2Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Federal District, Mexico, 3Mayo Clinic, Rochester, MN, 4University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 5Hospital Universitario Marques de Valdecilla, Santander, Spain, 6Umeå University, Umeå, Sweden, 7Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens. Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 8University of Witwatersrand, Johannesburg, South Africa, 9University of Witwatersrand, Johanessburg, South Africa, 10University of Mannitoba, Winnipeg, Canada, 11University of Mannitoba, Winnipeg, MB, Canada, 12Radboud University Medical Center, Nijmegen, Netherlands, 13Instituto Nacional de las Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 14Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 15UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 16Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 17Diakonhjemmet Hospital, Oslo, Norway, 18Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 19UCLouvain, Louvain, Belgium, 20University of Aarhus, Aarhus, Denmark, 21Aarhus Universitetshospital, Aarhus, Denmark, 22The Dudley Group NHS Foundation Trust, Birmingham, United Kingdom, 23The Lundquist Institute, Torrance, CA

    Background/Purpose: Rheumatoid arthritis (RA) activity associates with cardiovascular (CV) risk. Anticitrullinated protein antibodies (ACPA) were linked to higher activity and lower remission rates. Treatment responses…
  • Abstract Number: 1557 • ACR Convergence 2024

    Estimation of Cardiovascular Risk in Patients with Systemic Sclerosis – Accuracy of Tools Based on SCORE and Its Modifications Compared to Ultrasound Examination of Subclinical Atherosclerosis

    Sabína Oreská1, Aneta Prokopcová2, Hana Storkanova1, Jaroslav Kudlicka3, Vladimir Tuka4, Ondrej Mikes4, Zdislava Krupickova4, Martin Satny4, Eva Chytilova4, Jan Kvasnicka4, Maja Spiritovic5, Barbora Hermankova6, Petr Cesak7, Marian Rybar8, Karel Pavelka9, Ladislav Šenolt2, Radim Becvar1, Jiří Vencovský2, Michal Vrablik4 and Michal Tomcik1, 1Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 43rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, 5Institute of Rheumatology, Prague, Czech Republic, Prague, 6Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 7Department of Human Movement Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, 8Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic, Kladno, 9Institute of Rheumatology and Charles University, Praha, Czech Republic

    Background/Purpose: Patients with systemic sclerosis (SSc) have increased cardiovascular (CV) risk due to accelerated atherosclerosis (ATS) caused by systemic inflammation, and vascular impairment. To date,…
  • Abstract Number: 1565 • ACR Convergence 2024

    Prevalence and Risk Factors of Lower Extremities Arterial Disease in Systemic Sclerosis: Preliminary Data from a Single Centre Multidisciplinary Study

    Maria-Grazia Lazzaroni1, Paolo Baggi2, Liala Moschetti1, Eleonora Pedretti3, Elda Piovani1, Claudia Barison1, Emma Manzoni4, Franco Franceschini1, Stefano Bonardelli2 and Paolo Airò1, 1Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili, Brescia, Italy, Brescia, Italy, 2Vascular Surgery Unit, ASST Spedali Civili of Brescia, University of Brescia, Italy, Brescia, Italy, 3Scleroderma Unit, Rheumatology Unit, ERN ReCONNET, ASST Spedali Civili and University of Brescia; Italy, Brescia, Italy, 4University of Brescia, Brescia, Italy

    Background/Purpose: Microvascular changes represent a key step of pathogenic process in Systemic Sclerosis (SSc). However, SSc has been demonstrated to carry an increased risk of…
  • 1
  • 2
  • 3
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology